跳至主要内容
临床试验/IRCT2014051516563N2
IRCT2014051516563N2已完成2 期

Comparison of Effectiveness of Dorocontin and Sustak Drugs on Treatment of Ischemic Heart Disease

Dorsa Daroo Pharmaceutical Company0 个研究点目标入组 140 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
140

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
40 years 至 100 years(—)
性别
All

入选标准

  • Being higher than 40 years old
  • Having clinical signs of IHD (stable angina) like a chest pain which increases during activities and decreases during rest and usage of drug
  • Having background diseases (diabetes, kidney failure, hyperpressure, & ...)
  • Having clinical and lab signs of unstable angina or anfractuous (ECG changes along with increased levels of cardiac enzymes)
  • Simultaneous drug conflicts and bronchodilators such as calcium channel blockers, sildenafil

排除标准

  • 未提供

研究者

发起方
Dorsa Daroo Pharmaceutical Company

相似试验